Veriheal

AUGUST 25, 2021

It was during a public hearing on Saturday, July 24, 2021, that the Georgia Access to Medical Cannabis Commission (GMCC) awarded two Class 1 licenses and four Class 2 licenses to produce low-THC medical cannabis oil. The Haleigh’s Hope Act, otherwise known as Georgia’s HB 1 , was signed into effect by Governor Nathan Deal in April 2015.

Cultivation 98

Cultivation Oil THC Patients 98

Veriheal

MAY 20, 2021

Texas passed a medical cannabis law called the Compassionate Use Act in 2015. It allowed for low THC cannabis products for patients in Texas that had intractable epilepsy. Should the current bills pass for the State of Texas, it would expand the medical program opening a door for legal access for many more Texans.

Legalization 119

Legalization Chronic Pain Conditions THC 119

The Cannigma

APRIL 19, 2021

In recent years, lawmakers have eased up on a number of cannabis-derived formulations, and since 2015, people with epilepsy can obtain cannabis oil that contains less than 0.5% Patients do not need to register with the state or pay a fee to access the medical cannabis program. THC under the Texas Compassionate Use Ac t.

Law 84

Law Epilepsy Conditions Programs 84

Canna Care Docs

SEPTEMBER 18, 2020

Yes, you will be able to upload your records directly to your patient portal which you will receive access to. Governor Terry McAuliffe signed House Bill 1445 and Senate Bill 1235 in March 2015. These bills created the affirmative defense for possession of THC-A oil for the treatment of epilepsy.

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

Cannabis Law Report

FEBRUARY 19, 2022

As far back as 2015, Georgia established a Low THC Oil Patient Registry , which allowed qualified patients to possess cannabis oil with a total THC content of not more than 5%. Until 2019, however, no law provided a way to access that oil. As of 2015, however, Tennessee authorizes the use of cannabidiol oil with less than 0.9%

Legalization 97

Legalization Seed-To-Sale Programs Dispensary 97

Cannabis Law Report

MAY 16, 2019

It is claimed that medicinal cannabis can decrease anxiety, provide relief from chronic pain, alleviate nausea, assist symptoms of spasticity in people with multiple sclerosis and treat epilepsy. The 2016 Bill aimed to enable the cultivation of medicinal cannabis in Australia and improve access to the therapeutic drug for patients in need.

Medicine 45

Medicine Chronic Pain Access Patients 45

Cannabis Law Report

NOVEMBER 22, 2019

In Brazil, the initial step to allow the use of cannabis sativa for medical purposes was taken in 2014, when the Judiciary granted the first injunction to authorize a patient to import and use cannabidiol-rich oil (CBD) for the refractory epilepsy treatment. plant or substances obtained from it in its composition. Source: [link].

Sativa 59

Sativa Medicine Legalization Epilepsy 59

Sensi Seeds

JANUARY 7, 2019

As the legalization movement progresses opening the door for a wide range of cannabis products with potentially beneficial effects for many conditions including epilepsy , anxiety and obesity , it’s never been more important to have access to impartial scientific research.

Education 94

Education Dispensary Media Cannabis 94

The Cannigma

APRIL 12, 2023

Medical cannabis in Chile Chile legalized medical cannabis in 2015, allowing patients to access cannabis-based medicines with a prescription from a doctor. Patients can purchase cannabis-based medicines from authorized pharmacies, which are regulated by the Chilean Institute of Public Health.

Law 52

Law Decriminalization Recreational Epilepsy 52

Veriheal

SEPTEMBER 15, 2023

In 2015, Georgia passed HB 1, also known as the Haleigh’s Hope Act, allowing medical cannabis oil for medical use. The medical conditions that qualify for this program typically include severe and debilitating conditions like epilepsy, cancer, multiple sclerosis, and Parkinson’s disease, among others.

Programs 64

Programs Legalization Oil Conditions 64

Canna Care Docs

JUNE 21, 2022

Since 2015, Texans with certain medical conditions have had access to medical marijuana through the state’s Compassionate Use Program. These include: Epilepsy Seizure disorders Multiple sclerosis Spasticity Amyotrophic lateral sclerosis Autism Terminal cancer An incurable neurodegenerative disease Post-Traumatic Stress Disorder.

Programs 52

Programs Conditions Epilepsy THC 52

MassRoots

MAY 12, 2020

As a beacon of hope for patients in Georgia, an executive director has finally been appointed by the Access to Medical Cannabis Commission to oversee the next stages of development for the state’s medical marijuana program. A Brief History. For many patients, low-THC oil and CBD isolates simply are not enough to treat debilitating symptoms.

Oil 53

Oil Programs Access Patients 53

Cannabis Law Report

NOVEMBER 17, 2021

This National Epilepsy Awareness Month, TXOG advocates for the power of medical cannabis for epilepsy patients. Diagnosed with epilepsy at 3 years old, Ortiz would experience erratic, unpredictable seizure clusters, each lasting 20 minutes. We remain committed to advancing safe, legal access to this powerful medicine.

Patients 40

Patients Epilepsy Medicine Advocacy 40

MMJ Recs

DECEMBER 13, 2023

Let’s take a look at the current state of medical marijuana dispensaries in Texas, examining the legal framework, patient access, and the potential impact on the healthcare landscape. Qualifying conditions include epilepsy, terminal cancer, multiple sclerosis, autism, and incurable neurodegenerative diseases.

Dispensary 52

Dispensary Patients Marijuana Epilepsy 52

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. Current Texas Medical Marijuana Regulations CBD laws in Texas are governed by the Compassionate Use Program.

Law 52

Law Clinical Trials Dispensary Programs 52

MMJ Recs

APRIL 20, 2022

Because of the push towards easier access to alternative medicines, MMJ has been slowly growing into a beneficial and profitable industry. It wasn’t until 2014 and 2015 that the state began to see action in terms of accessing and using medical marijuana for health conditions.

Patients 52

Patients Marijuana Access Dispensary 52

Canna Care Docs

DECEMBER 16, 2020

The difference is that medical patients may have access to higher dosages, among other benefits depending on their state, and receive a higher level of service to match them with the best products for their symptoms. What conditions is medical marijuana helpful for? Nausea and vomiting.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

Cannabis Law Report

SEPTEMBER 28, 2019

Access for patients: Czech Republic confirms medical cannabis subsidies. Access for patients: Czech Republic confirms medical cannabis subsidies. A symposium in Limerick has heard that the medical cannabis access programme here is too restrictive and needs to be extended to include people who suffer with chronic pain.

Epilepsy 40

Epilepsy Chronic Pain Medicine Pharmaceutical 40

Cannabis Law Report

NOVEMBER 13, 2019

The appointments were a key step for patients who have been allowed to use the drug since 2015 but had no legal way to buy, grow or transport it. The Georgia Access to Medical Cannabis Commission includes three doctors, a police chief, a health policy professor, the president for the Georgia Board of Pharmacy and a small-business owner.

Programs 45

Programs Oil Patients Access 45

PrestoDoctor

SEPTEMBER 22, 2023

The Compassionate Use Act, enacted in 2015, allows for the medical use of low-THC cannabis oil by patients with certain qualifying conditions. These conditions include epilepsy, multiple sclerosis, terminal cancer, incurable neurological disorders, and a list of others. or less) and high levels of CBD.

Legalization 52

Legalization Dispensary Recreational Legislation 52

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. tetrahydrocannabinol (THC).

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Veriheal

OCTOBER 5, 2020

The qualifying conditions for medical cannabis has been established in the bill as follows: Amyotrophic Lateral Sclerosis (ALS), Cachexia, Cancer, Chronic Pain, Crohn’s Disease, Epilepsy, Glaucoma, HIV/Aids, Lupus, Multiple Sclerosis, Nausea, Persistent Muscle Spasms, Post-traumatic Stress Disorder (PTSD), Rheumatoid Arthritis. .

Edibles 52

Edibles Legalization Decriminalization Consumption 52

The Cannigma

AUGUST 8, 2022

Several bills have been introduced as far back as 2015 , and more recently in 2021 and 2022 to create a legal medical or adult-use program in Kentucky, but all have failed. Kentucky legalized CBD before it was federally legal, creating access for medical patients back in 2014. How do people in Kentucky view cannabis?

Law 52

Law Programs Hemp Cannabis 52

The Cannigma

MARCH 12, 2021

At the end of the episode, Debbie Churgai, executive director of Americans for Safe Access, discusses the various ways that military veterans — who could very much benefit from medical cannabis — have difficulty accessing it and the ways that the Veterans Administration can address that issue. Produced by Michael Schaeffer Omer-Man.

Legalization 128

Legalization Patients Education Dispensary 128

Veriheal

MAY 31, 2022

opioid epidemic, which claimed a record number of lives in 2021 , is the result of America’s faulty regulation of these powerful pain-killing drugs and a widespread lack of access to safe and adequate pain management solutions. state in both geographic area and population , access to online medical cannabis consultations is crucial.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

DECEMBER 9, 2019

Up until December of 2015, regulatory limitations put in place by the FDA prohibited researchers from conducting CBD-related trials in the US. As CBD becomes increasingly prevalent, accessible and mainstream, it is expected that pet-related CBD products will continue to represent a massive opportunity for brands in the market.

Pets 45

Pets CBD Research and Development Epilepsy 45

StrainConnect

FEBRUARY 8, 2019

From cancer(11) to epilepsy(12), there seems to be very little that cannabis cannot help with. A 2015 Israeli study found that full-spectrum CBD oil is effective at much lower doses and has a wider therapeutic window than a CBD isolate(17). Endocannabinoids and epilepsy - Science Direct. Accessed 9 Feb. Cannabis sativa L.

Hemp 57

Hemp CBD Cannabinoids Sativa 57

Cannabis Law Report

SEPTEMBER 23, 2019

Surveying marijuana use is essential to gauge public health implications of increased access to marijuana, cannabinoid, and cannabis products. 7 While the lifetime use remains relatively stable for this cohort, from 2015-2017, past year and past month use increased 2.7% Accessed August 20, 2019. Accessed August 20, 2019.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Weedistry

MARCH 8, 2019

In 2018, medical cannabis became legal in the UK after a nationwide outpouring of support for two young boys who rely on cannabis oil to treat their severe and rare forms of epilepsy, but lingering concerns around the safety and efficiency of the medicine mean that access is still heavily restricted. THC – between 2015 and 2017.

Oil 40

Oil Treatment Patients THC 40

Cannabis Law Report

MAY 6, 2022

Since 2015, the FDA has sent warning letters to companies allegedly illegally selling unapproved cannabinoid (CBD) products. Examples of sellers’ language the FDA views as illegal are the following: “Our line of …CBD oil … is great for insomnia, epilepsy, MS, schizophrenia, and chronic pain.”.

THC 52

THC CBD Media Food 52

Cannabis Law Report

OCTOBER 26, 2019

iv Named-patient and compassionate use proceduresThe TG Act provides mechanisms that allow individuals to gain limited access to UTGs (defined in Section II.iii). The Special Access Scheme (SAS) provides three pathways for access to UTGs: a Category A is a notification pathway that can only be accessed by medical practitioners (i.e.,

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Alchimia

JANUARY 4, 2016

The three most populated Australian States (Victoria, New South Wales, Queensland) promised to organize studies on the efficiency of cannabis to alleviate terminally ill patients, controlling severe epilepsy in children, as well as for the treatment of side effects of chemotherapy. But on August 17, 2015 a judge has authorized Graciela?s

Marijuana 48

Marijuana Epilepsy Pharmaceutical Chronic Pain 48

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.

Research and Development 52

Research and Development Medicine Access Media 52

Greencamp

AUGUST 16, 2018

The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies). Exploring the available research on ALS and cannabinoids.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Cannabis Law Report

JANUARY 26, 2022

MAPS Public Benefit Corporation will coordinate trial design with Medicines and Healthcare products Regulatory Agency to create a road map for early patient access in the UK. It is estimated that, in 2015, 3% of people in the UK were living with PTSD. Our promising Phase 3 results lead us to apply for the Innovation Passport.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Cannabis Law Report

OCTOBER 24, 2019

It will allow for regulated, supervised and limited access for our sick citizens especially those with cancer, HIV/ AIDS, glaucoma, and epilepsy. ANGUILLA | Status: Medicinal + Decriminalisation Being Debated. Anguilla has proposed new Cannabis decriminalization laws. The oils can be legally imported. CUBA | Status: Illegal.

Law 45

Law Medicine Decriminalization Oil 45

Cannabis Law Report

JANUARY 30, 2019

Access the full document at. While this is a positive step and will provide a new treatment option for those with two types of intractable epilepsy, it is my understanding that this scheduling action relates only to CBD in an FDA-approved formulation. Access the full document at. Senator Grassley Questions Pages 6 & 7.

Research and Development 63

Research and Development DEA CBD Law 63